Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking oral semaglutide correctly makes a real difference to how well it works. The Wegovy tablet must be swallowed whole, first thing in the morning on an empty stomach, with a small amount of plain water — no more than about 120ml — and you need to wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. That waiting window is not a suggestion; it is the mechanism. Semaglutide in tablet form uses an absorption enhancer called SNAC to carry the medicine across the stomach lining, and food or coffee in the way sharply reduces how much reaches your bloodstream. Wegovy tablets are a once-daily oral treatment approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management. Like all GLP-1 medicines, they are prescription-only: a prescriber assesses whether the treatment is suitable for you before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The alarm goes off. Before you put the kettle on, before you reach for your phone charger, you take your Wegovy tablet. One small glass of plain water, tablet in, swallowed whole. Then you wait. Thirty minutes at minimum, some people set a second alarm so they do not drift back to sleep and forget. After that half-hour, breakfast, coffee, your other medicines: all fine.
The sequence sounds simple, but the temptation to blur the edges is real. A question our prescribers hear most weeks is whether a small black coffee counts as a drink or just a liquid. It counts as a drink. Anything other than plain water before the waiting period ends will reduce how much semaglutide your body absorbs, which means you get less effect from the same dose. The full guidance on taking semaglutide tablets covers this in more detail, but if you want to understand exactly how to take semaglutide tablets for weight loss, including the timing, water rules and what counts as breaking the fast, that dedicated page walks you through it step by step.
The tablet should be swallowed whole. Do not crush, split or chew it. The SNAC absorption enhancer is built into the tablet's structure and needs to reach the stomach intact. Store the pack at room temperature, away from direct sunlight. Unlike the weekly injection, there is no fridge to remember, one less thing to manage.
Oral semaglutide for weight loss starts at 1.5mg daily. That dose is lower than most people expect, and it exists entirely to let your digestive system adjust before the medicine reaches a level where it has a meaningful effect on appetite. After at least a month, a prescriber may move you to 4mg, then 9mg, then the 25mg maintenance dose, each step requiring at least a month at the previous level. Rushing the schedule does not speed up results; it raises the chance of nausea and vomiting that makes the whole thing harder to stick with.
If you are already established on the 2.4mg weekly injection, MHRA guidance notes that a switch directly to the 25mg tablet may be appropriate, subject to clinical assessment. That is not a decision to make unilaterally. For anyone curious how the tablet compares to the injection on a practical and clinical level, the comparison of oral semaglutide versus the injection sets out the key differences. The evidence base for the tablet comes from the OASIS 4 phase-3 trial, which reported an average weight loss of around 13.6% over 64 weeks against placebo, and closer to 17% among participants who stayed fully adherent throughout, as published at MHRA approval in June 2026. That adherence figure matters: the tablet's performance depends more on consistent, correct use than the injection does, simply because absorption is more sensitive to how it is taken.
The guidance on how to use semaglutide tablets for weight loss goes into the lifestyle adjustments that complement the schedule.
If you miss a dose and remember the same morning, still more than 30 minutes before your first food or drink, take it then. If you have already eaten or it is later in the day, skip that day entirely and continue the next morning as normal. Do not double up. Two doses in quick succession will not help and may make side effects considerably worse.
The most commonly reported side effects are gastrointestinal: nausea, loose stools, constipation and indigestion are the ones most people encounter, particularly in the first few weeks at a new dose. In the OASIS 4 trial, about 74% of participants on active treatment reported a GI side effect at some point, versus around 42% on placebo, most were mild to moderate and settled as the body adjusted. Eating smaller meals, keeping well hydrated and avoiding rich or fatty food in the early weeks all help. The NHS semaglutide medicines page lists the full side-effect profile and when to seek medical attention.
One set of symptoms should always prompt urgent help: severe stomach pain that extends towards the back, with or without vomiting. This can be a sign of pancreatitis, which the MHRA highlighted as a known, infrequent but serious risk in a Drug Safety Update for GLP-1 medicines. Do not wait to see if it settles, contact a doctor or 111 promptly. Any suspected side effects can be reported at the MHRA's Yellow Card scheme.
Oral semaglutide suits people who strongly prefer not to inject, travel frequently, or simply find a daily tablet easier to build into a routine than a weekly pen. It does not require refrigeration, there are no needles involved, and the dosing logic is familiar. The trade-off is that correct use demands more discipline than the injection, the 30-minute fast, every single morning, is non-negotiable. For people who have busy, variable mornings, that structure can feel like a lot.
Whether the tablet or the injection is the better fit for your life and health history is exactly the kind of thing a prescriber thinks through with you. People weighing up the two options often find the evidence on how the tablet compares to the injection in practice useful reading before their consultation. For context on what a private prescription involves and what treatment pricing reflects, the weight-loss treatment overview covers cost and what is included. If you are ready to have that clinical conversation, speaking to our prescribers is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.